Tag Archives: Covid-19

Civets in the Wuhan Institute of Virology 2018-2019: resist speculation

By on .

By Daniel R. Lucey, MD, MPH, FIDSA In the interview between Science writer Jon Cohen and the renowned scientist Dr. Zhengli Shi of the Wuhan Institute of Virology, published online in July 2020, Cohen asks the question (under #18(3) on p. 6 of a nine-page PDF): “Has your lab done any animal experiments with SARS-related […]

Global vaccine equity is within reach if we act now

By on .

By Amir M. Mohareb, MD, Louise C. Ivers, MD, MPH, Rajesh T. Gandhi, MD, and Shahin Lockman, MD, MSc As the U.S. convenes a global COVID-19 summit at the UN, discussions about COVID-19 vaccines are bringing new voices to an old conversation. How — and when — should essential medical technologies, such as COVID-19 vaccines, […]

The early days of a campus COVID-19 response: pivot and pivot again

By on .

By Lisa V. Adams, MD, and Kavita Kantamneni, MPH When Lisa describes her early days on Dartmouth’s COVID-19 response, she asks people to recall their “first COVID-19 moment,” that instant when they realized this was not a drill, that this was going to be something big and life-altering. For her, that was on Jan. 31, […]

Comments on key documents from the early weeks of SARS-CoV-2

By on .

By Daniel R. Lucey MD, MPH, FIDSA The purpose of this blog is to provide comments on reporting of some of the key COVID-19 events from 23 Chinese publications dated Dec. 31, 2019, until Feb. 17, 2021. Except for the five from the China CDC Weekly website, most are no longer online; however, I saved […]

IDWeek 2020: Dr. Fauci opens “Chasing the Sun” with a view of COVID-19 in the U.S.

By on .

“His advice is honest and rooted in sound science,” former President George W. Bush “He’s the guy I’ve gone to since 1993 . . . and still do,” National Institutes of Health Director Dr. Francis Collins “Thank you for what you do and who you are,” World Health Organization Director-General Tedros Adhanom Ghebreyesus The former President […]

Regeneron REGN-COV2 monoclonal antibody reported better in (non-hospitalized) patients who lack their own antibodies to SARS-CoV-2

By on .

By Daniel R. Lucey M.D., MPH, FIDSA In assessing any potential benefit on symptom duration or viral load reduction, let alone “cure,” it is important to know whether non-hospitalized patients are already making their own antibodies against SARS-CoV-2 at the time they receive the Regeneron ”REGN-COV2 cocktail” of two monoclonal antibodies against the spike protein […]

Dr. Fauci Speaks: Takeaways from a discussion on COVID-19

By on .

National Institutes of Allergy and Infectious Diseases Director Dr. Anthony Fauci talked with Dr. Carlos del Rio for an Infectious Diseases Society of America podcast, released today, on challenges of, and answers to, the COVID-19 pandemic. The two physician scientists, both IDSA members, discussed the outlook for a safe and effective vaccine, testing strategies needed, […]

Racism, not race, is a risk factor for infectious diseases

By on .

By Ayesha Khan, Ph.D. As the COVID-19 pandemic circles the world, every country that confronts it has unique challenges when it comes to their pandemic responses. The United States has some of the greatest structural challenges, and they run deep. America is combatting a pandemic — COVID-19 — in the context of a more than […]

COVID-19: Eight questions for the WHO team going to China next week to investigate pandemic origins

By on .

By Daniel R. Lucey M.D., MPH, FIDSA Today the South China Morning Post reported that on Monday the World Health Organization Director General Tedros Adhanom Gehbreysus stated “We can fight the virus better when we know everything about the virus, including how it started . . .We will be sending a team next week to […]

COVID-19: In Beijing a new outbreak linked with large market “Xinfadi” 

By on .

By Daniel R. Lucey M.D., MPH, FIDSA In a growing series of events in Beijing over the past 48 hours a new outbreak has been reported with an epidemiological link to the largest food market, called “Xinfadi”, in the city. The main China Center for Disease Control in Beijing, and the overarching China National Health […]